Virginia Retirement Systems’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$766K Sell
29,650
-7,700
-21% -$217K ﹤0.01% 794
2026
Q2
$1.15M Buy
37,350
+11,100
+42% +$274K 0.01% 710
2026
Q1
$567K Hold
26,250
– – ﹤0.01% 733
2025
Q4
$626K Sell
26,250
-1,250
-5% -$25.5K ﹤0.01% 706
2025
Q3
$374K Sell
27,500
-8,700
-24% -$90.5K ﹤0.01% 810
2025
Q2
$295K Sell
36,200
-7,800
-18% -$66.6K ﹤0.01% 842
2025
Q1
$345K Buy
+44,000
New +$510K ﹤0.01% 851
2023
Q3
$449K Sell
25,000
-15,200
-38% -$305K ﹤0.01% 724
2023
Q2
$816K Sell
40,200
-18,600
-32% -$354K 0.01% 602
2023
Q1
$1.07M Buy
58,800
+9,200
+19% +$176K 0.01% 529
2022
Q4
$1.03M Buy
49,600
+9,400
+23% +$259K 0.01% 602
2022
Q3
$1.05M Buy
+40,200
New +$1.06M 0.01% 563
2021
Q3
– Sell
-10,400
Closed -$286K – 1065
2021
Q2
$286K Buy
10,400
+1,100
+12% +$31.4K ﹤0.01% 930
2021
Q1
$261K Buy
9,300
+100
+1% +$3.48K ﹤0.01% 1026
2020
Q4
$239K Buy
+9,200
New +$223K ﹤0.01% 1024

Other funds holding RCUS

Virginia Retirement Systems's RCUS Position: Q3 2026 in Review

Virginia Retirement Systems reduced its Arcus Biosciences (RCUS) stake by 21% in Q3 2026, selling an estimated $217K and leaving 29,650 shares worth $766K. The position accounts for ﹤0.01% of the portfolio, ranked #794.

Virginia Retirement Systems first reported a position in RCUS in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.15M in Q2 2026. 111 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • Virginia Retirement Systems held 29,650 shares of Arcus Biosciences worth $766K as of Q3 2026.
  • Virginia Retirement Systems sold 7,700 Arcus Biosciences shares in Q3 2026, an estimated $217K.
  • Arcus Biosciences made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q3 2026, its #794 holding.
  • Virginia Retirement Systems first reported a position in Arcus Biosciences in Q4 2020 and has held it in 15 quarters since.
  • Virginia Retirement Systems's Arcus Biosciences position peaked at $1.15M in Q2 2026.
  • 111 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.